REHOVOT, Israel, Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company, today announced that Ofer Haviv, Evogene's President and CEO, will present at the H.C. Wainwright 27th Annual Global Investment Conference, 2025, taking place in New York, from September 8-10, 2025. SOURCE Evogene Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) is a pioneering AI-driven discovery and development company focused on creating novel small molecules for the pha ...